Pharmaceuticals
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Trend Stats
Today's % Change
-0.47%
1-Month Return
-2.79%
3-Month Return
+4.69%
12-Month Return
+24.22%
Volatility Score
1.8
ST Trend
Down
LT Trend
Up
Short-Term Trend
Down
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Pharmaceuticals
S&P 500 Index
Components
| Symbol | Company | Market Cap | % change Today's percentage change | 1 mo return Performance over the past month | 12 mo return Performance over the past 12 months | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $1T | -0.11% | -8.71% | +49.43% | 3.0 | Down | Up |
| JNJ | Johnson&Johnson | $642B | -0.27% | +2.24% | +52.58% | 2.0 | Neutral | Up |
| ABBV | AbbVie | $451B | +1.63% | +2.84% | +19.39% | 2.2 | Neutral | Up |
| MRK | Merck | $357B | -1.91% | +10.53% | +75.63% | 3.0 | Up | Up |
| NVS | Novartis Sp ADR | $261B | +0.00% | -12.32% | +10.91% | 3.1 | Down | Down |
| AZN | ASTRAZENECA | $248B | +1.72% | -1.40% | +0.11% | 2.0 | Down | Down |
| NVO | Nordisk Sp ADR-B | $194B | -1.23% | -6.62% | -15.04% | 2.8 | Down | Down |
| PFE | Pfizer | $158B | -0.47% | +2.22% | +19.02% | 2.1 | Up | Up |
| BMY | Bristol-MyersSqu | $130B | -1.02% | -1.68% | +40.53% | 2.3 | Neutral | Up |
| MCK | Mckesson | $103B | -1.21% | +0.22% | +22.86% | 2.5 | Up | Up |
| SNY | SANOFI SP ADR | $102B | -0.30% | -1.75% | -5.38% | 1.6 | Down | Down |
| GSK | GSK Sp ADR | $96B | -1.05% | -6.91% | +20.12% | 2.1 | Down | Down |
| COR | Cencora | $61B | -0.73% | -1.05% | +6.80% | 2.4 | Neutral | Neutral |
| TAK | TAKEDA PHARM SP ADR | $58B | -0.55% | +3.19% | +22.79% | 1.5 | Up | Up |
| TEVA | TEVAPHARMIND SP ADR | $42B | -1.36% | +0.58% | +82.76% | 2.8 | Up | Up |
| HLN | Haleon Sp ADR | $41B | -0.11% | -6.54% | -4.70% | 1.9 | Down | Down |
| ZTS | Zoetis-A | $30B | -0.61% | -2.63% | -50.69% | 3.1 | Down | Down |
| VTRS | Viatris | $19B | -0.73% | +1.37% | +66.77% | 2.4 | Down | Up |
| JAZZ | Jazz Pharmaceuti | $16B | -0.34% | -6.25% | +87.20% | 3.0 | Down | Up |
| CORT | Corcept Therapeu | $12B | -0.67% | +0.60% | +54.61% | 3.8 | Up | Up |
| ELAN | ELANC ANIML HLTH | $11B | -2.93% | +2.60% | +21.73% | 3.3 | Down | Down |
| AXSM | Axsome Therapeut | $11B | +0.23% | -4.43% | +71.69% | 3.0 | Down | Up |
| OGN | Organon | $3.6B | -0.29% | +0.22% | +28.90% | 0.3 | Neutral | Up |
| BHC | BAUSCH HEALTH | $2.3B | -1.46% | -4.41% | -16.28% | 5.0 | Up | Up |
| PRGO | Perrigo | $1.9B | -5.23% | +9.73% | -34.05% | 4.3 | Up | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |
